These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6080893)

  • 1. [Fibrinolytic diathesis following surgery of the prostate].
    Ambroz W; Kuznik Z; Polubiec A
    Pol Przegl Chir; 1967 Oct; 39(10):Suppl:1098+. PubMed ID: 6080893
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolysis and loss of blood following prostatic surgery and their susceptibility to antifibrinolyties. Epsilon aminocaproic acid and the kallikrein inhibitor trasylol].
    Schmutzler R; Fürstenberg H
    Dtsch Med Wochenschr; 1966 Feb; 91(7):297-303. PubMed ID: 5295336
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes of blood coagulation in prostatic surgery, consequences for preventive therapy with antifibrinolytic agents].
    Naber K; Bichler KH; Müller KH; Sommerkamp H; Jöhrens H; Porzsolt F
    Helv Chir Acta; 1973 Sep; 40(4):519-22. PubMed ID: 4753393
    [No Abstract]   [Full Text] [Related]  

  • 4. [The postoperative hemorrhage in the prostate surgery].
    Lennert KA; Hepp G
    Bruns Beitr Klin Chir (1971); 1967 Nov; 215(3):313-20. PubMed ID: 4172497
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiopathology and treatment of the acute fibrinolytic syndrome (illustration of 2 cases)].
    Zeni L
    Minerva Anestesiol; 1965 Sep; 31(9):436-8. PubMed ID: 5854638
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current strategies to minimize of blood loss during radical prostatectomy].
    Strang CM; Hachenberg T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jul; 48(7-8):494-9; quiz 500-1. PubMed ID: 23929170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of PAMBA in urology].
    Hellinger J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):187-96. PubMed ID: 4174658
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evolution in the treatment of fibrinolytic hemorrhage in prostatic surgery].
    Caldarelli GF; Angeletti CA; Esposito R
    Ann Ital Chir; 1967; 43(3):513-26. PubMed ID: 5608283
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemorrhagic complications following prostatectomy].
    Anger G; Willing E
    Z Urol Nephrol; 1978 Nov; 71(11):815-20. PubMed ID: 735474
    [No Abstract]   [Full Text] [Related]  

  • 10. [The significance of local fibrinolysis increase in symptomatic hematuria and its inhibition by p-aminomethylbenzoic acid].
    Hellinger J
    Z Urol Nephrol; 1966 Sep; 59(9):633-9. PubMed ID: 5997446
    [No Abstract]   [Full Text] [Related]  

  • 11. AMCA (aminomethyl cyclohexane carboxylic acid, Cyklo-kapron) a potent haemostatic agent in urinary tract bleeding.
    Andersson L; Nilsson IM
    Scand J Urol Nephrol; 1969; 3(3):169-76. PubMed ID: 5393836
    [No Abstract]   [Full Text] [Related]  

  • 12. A bleeding tongue - acute presentation of fibrinolysis.
    Hodson A; Hunt BJ
    Int J Lab Hematol; 2007 Oct; 29(5):393-4. PubMed ID: 17824923
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of epsilon-aminocaproic acid and trasylol on fibrinolysis and blood loss after operations on the prostate.
    Schmutzler R; Fürstenberg H
    Ger Med Mon; 1966 Oct; 11(10):391-6. PubMed ID: 5927723
    [No Abstract]   [Full Text] [Related]  

  • 14. Amicar and hyperfibrinolysis.
    Med Lett Drugs Ther; 1967 Jan; 9(3):10-1. PubMed ID: 6067964
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemostatic status in prostatectomy & the effect of para-aminomethyl benzoic acid on anti-fibrinolysis.
    Ambasta SS; Shukla KK; Dube RK; Dube B
    Indian J Med Res; 1988 Jul; 88():57-9. PubMed ID: 3263323
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological aspects of fibrinolysis].
    Prino G; Mantovani M
    Boll Chim Farm; 1969 Dec; 108(12):727-60 passimf. PubMed ID: 4911753
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coagulation physiological bases of antifibrinolytic treatment in prostatectomies].
    Neef H; Preusser KP; Anger G; Richter M
    Zentralbl Chir; 1967 Apr; 92(13):486-90. PubMed ID: 5591468
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reduction of post-prostatectomy bleeding by medication (experience with the antifibrinolytic agent AMCA)].
    Kaufmann J; Siefker K
    Urologe; 1969; 8(2):57-9. PubMed ID: 5360135
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the physiology of blood coagulation and fibrinolysis as the basic principles in the clinical use of anticoagulants, thrombolytics and inhibitors of fibrinolysis].
    Van de Loo J
    Rev Colomb Obstet Ginecol; 1967; 18(5):321-6. PubMed ID: 5612568
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tumor fibrinolysis and antifibrinolytic agents].
    Peterson HI
    Lakartidningen; 1978 Feb; 75(6):441-3. PubMed ID: 628254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.